- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Classical Hodgkin Lymphoma in United Kingdom
Total 5634 results
-
National Cancer Institute (NCI)TerminatedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemias | Multiple Myeloma With PlasmacytomaUnited States
-
Spectrum Pharmaceuticals, IncCTI BioPharmaTerminatedLymphoma, Follicular | Follicular LymphomaUnited States
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL) | Non-Hodgkin's Lymphoma (NHL)United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
University of WashingtonRecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin LymphomaUnited States
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Hoffmann-La RocheActive, not recruitingB-cell Non-Hodgkin LymphomaUnited States, Canada, Belgium, Spain, United Kingdom
-
St. Jude Children's Research HospitalCompleted
-
Bristol-Myers SquibbCompletedHodgkin's DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterCephalonCompletedLymphoma | Hodgkin's DiseaseUnited States
-
TG Therapeutics, Inc.TerminatedMantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Waldenstrom's Macroglobulinemia | Non-Hodgkins Lymphoma | Small Lymphocytic Lymphoma | B-cell LymphomasUnited States
-
National Cancer Institute (NCI)CompletedAlisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell LymphomasRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation RecipientUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | CD20-Positive Neoplastic Cells Present | Refractory Mature B-Cell Non-Hodgkin LymphomaUnited States
-
Robert KranceBaylor College of Medicine; The Methodist Hospital Research Institute; Center...CompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Shams ShakilCelgeneCompletedLymphoma | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
Emory UniversityCelgene CorporationTerminatedB-Cell Lymphoma | Hodgkin's DiseaseUnited States
-
Seagen Inc.Bristol-Myers SquibbCompletedHodgkin Disease | Peripheral T Cell LymphomaUnited States, Canada
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid TumorCanada, United States
-
Stanford UniversityThe Leukemia and Lymphoma Society; Biospect IncRecruitingLymphoma, Non-Hodgkin | Hodgkin's DiseaseUnited States
-
Spectrum Pharmaceuticals, IncNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedAcute Myeloid Leukemia | Leukemia | Multiple Myeloma | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Non-Hodgkins Lymphoma | Myeloproliferative Diseases | Hodgkins LymphomaUnited States
-
GenmabAbbVieRecruitingDiffuse Large B-Cell Lymphoma | Classic Follicular LymphomaUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedHodgkin's LymphomaUnited States, Belgium, Germany, Canada, Singapore, Netherlands, France, Australia, Russian Federation, Israel, Brazil, Italy, New Zealand, Poland
-
Washington University School of MedicineCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
Washington University School of MedicineCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
GlaxoSmithKlineCompletedNon-Hodgkin's LymphomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis PharmaceuticalsTerminatedNon-Hodgkin's LymphomaUnited States
-
Gilead SciencesCompletedFollicular Non-Hodgkin's Lymphoma RefractorySpain, France, Ireland, Italy, Greece, Germany, United Kingdom, Sweden, Belgium, Portugal
-
University of RochesterCompletedLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
University College, LondonBristol-Myers SquibbActive, not recruitingHodgkin LymphomaUnited Kingdom
-
National Cancer Institute (NCI)CompletedT Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesLymphoma, B-Cell | Lymphoma, Non-hodgkinsUnited States
-
Beth ChristianCompletedRecurrent Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin Lymphoma | Adult Nodular Lymphocyte Predominant Hodgkin LymphomaUnited States
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Central Nervous System Lymphoma | Gastric Mantle Cell Lymphoma | Splenic Mantle Cell LymphomaUnited States
-
Beth ChristianGilead SciencesCompleted
-
Fate TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Non-Hodgkin's Lymphoma (NHL) | Hodgkin's Disease | Acute Myelogenous Leukemia (AML)United States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic... and other conditionsUnited States
-
University Hospital Southampton NHS Foundation...Cancer Research UK; The Christie NHS Foundation Trust; Celldex Therapeutics; Oxford... and other collaboratorsActive, not recruitingB Cell LymphomaUnited Kingdom
-
Washington University School of MedicineCelgene CorporationCompletedHodgkin DiseaseUnited States
-
National Cancer Institute (NCI)CompletedLymphoma, Non-Hodgkin | Hodgkin's DiseaseUnited States
-
PRAECIS Pharmaceuticals Inc.TerminatedSolid Tumors | Non-Hodgkin's Lymphoma,United States
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
Mayo ClinicRecruitingIndolent Non-hodgkin Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-hodgkin's Lymphoma | Small Lymphocytic LymphomaUnited States